Helius Medical Technologies is trading 11.13% up at $2.31, with the move appearing primarily sector-driven amid strong medical-device results.
- No credible September 3, 2026 company-specific announcement or filing was identified.
- Medtronic posted a revenue beat and raised fiscal 2027 guidance, supporting healthcare stocks.
- Broader risk-on sentiment is supportive, with major U.S. indexes gaining more than 1%.